Geode Capital Management’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-624,146
| Closed | -$3.22M | – | 4301 |
|
|
2019
Q2 | $3.22M | Buy |
624,146
+52,062
| +9% | +$234K | ﹤0.01% | 2648 |
|
|
2019
Q1 | $2.06M | Buy |
572,084
+45,755
| +9% | +$198K | ﹤0.01% | 2828 |
|
|
2018
Q4 | $3.23M | Buy |
526,329
+91,968
| +21% | +$561K | ﹤0.01% | 2492 |
|
|
2018
Q3 | $2.54M | Buy |
434,361
+31,312
| +8% | +$156K | ﹤0.01% | 2758 |
|
|
2018
Q2 | $1.71M | Buy |
403,049
+86,114
| +27% | +$434K | ﹤0.01% | 2942 |
|
|
2018
Q1 | $1.4M | Buy |
316,935
+3,309
| +1% | +$14.8K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $1.65M | Buy |
313,626
+21,654
| +7% | +$132K | ﹤0.01% | 2862 |
|
|
2017
Q3 | $1.79M | Buy |
291,972
+5,373
| +2% | +$34K | ﹤0.01% | 2818 |
|
|
2017
Q2 | $2.07M | Buy |
286,599
+43,247
| +18% | +$266K | ﹤0.01% | 2712 |
|
|
2017
Q1 | $1.29M | Buy |
243,352
+10,465
| +4% | +$70.7K | ﹤0.01% | 2894 |
|
|
2016
Q4 | $1.67M | Buy |
232,887
+26,332
| +13% | +$213K | ﹤0.01% | 2726 |
|
|
2016
Q3 | $1.93M | Buy |
206,555
+17,370
| +9% | +$144K | ﹤0.01% | 2579 |
|
|
2016
Q2 | $1.2M | Buy |
189,185
+5,304
| +3% | +$34.1K | ﹤0.01% | 2804 |
|
|
2016
Q1 | $1.01K | Buy |
183,881
+2,550
| +1% | +$9.59K | ﹤0.01% | 2872 |
|
|
2015
Q4 | $1.01M | Buy |
181,331
+1,551
| +0.9% | +$10.3K | ﹤0.01% | 2909 |
|
|
2015
Q3 | $1.52M | Buy |
179,780
+4,063
| +2% | +$68.8K | ﹤0.01% | 2617 |
|
|
2015
Q2 | $2.66M | Buy |
175,717
+997
| +0.6% | +$14.4K | ﹤0.01% | 2317 |
|
|
2015
Q1 | $2.8M | Buy |
174,720
+2,697
| +2% | +$48K | ﹤0.01% | 2225 |
|
|
2014
Q4 | $3.06M | Buy |
172,023
+49,210
| +40% | +$613K | ﹤0.01% | 2132 |
|
|
2014
Q3 | $1.23M | Buy |
122,813
+15,961
| +15% | +$194K | ﹤0.01% | 2662 |
|
|
2014
Q2 | $1.67M | Buy |
106,852
+12,436
| +13% | +$176K | ﹤0.01% | 2490 |
|
|
2014
Q1 | $1.75M | Buy |
94,416
+60,226
| +176% | +$1.21M | ﹤0.01% | 2415 |
|
|
2013
Q4 | $653K | Buy |
34,190
+732
| +2% | +$14.9K | ﹤0.01% | 2950 |
|
|
2013
Q3 | $547K | Buy |
+33,458
| New | +$352K | ﹤0.01% | 2903 |
|
Other funds holding PETX
Geode Capital Management's PETX Position: Q3 2019 in Review
Geode Capital Management sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 624,146 shares — an estimated $3.22M sold.
Geode Capital Management first reported a position in PETX in Q3 2013 and held it in 24 quarters. The position peaked at $3.23M in Q4 2018. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Geode Capital Management reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Geode Capital Management sold 624,146 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $3.22M.
- Geode Capital Management first reported a position in Aratana Therapeutics, Inc. in Q3 2013 and held it in 24 quarters.
- Geode Capital Management's Aratana Therapeutics, Inc. position peaked at $3.23M in Q4 2018.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Geode Capital Management's 13F filing for Q3 2019, filed 12 Nov 2019.